Quick Answer
INCYTE CORP reported R&D Expense of $2.05 billion for fiscal year 2025.
INCYTE CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.05B | -21.4% |
| 2024 | $2.61B | +60.2% |
| 2023 | $1.63B | +2.6% |
| 2022 | $1.59B | +8.8% |
| 2021 | $1.46B | -34.2% |
| 2020 | $2.22B | +92.0% |
| 2019 | $1.15B | -3.7% |
| 2018 | $1.20B | -9.7% |
| 2017 | $1.33B | +127.9% |
| 2016 | $581.86M | +21.3% |
| 2015 | $479.51M | +38.0% |
| 2014 | $347.52M | +33.4% |
| 2013 | $260.44M | +23.8% |
| 2012 | $210.39M | +17.7% |
| 2011 | $178.71M | +44.3% |
| 2010 | $123.88M | +3.7% |
| 2009 | $119.44M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $506.58M | -11.6% | +2.4% |
| June 30, 2025 | $494.92M | -56.5% | +13.2% |
| March 31, 2025 | $437.28M | +1.9% | -23.7% |
| September 30, 2024 | $573.17M | +52.6% | -49.7% |
| June 30, 2024 | $1.14B | +184.1% | +165.2% |
| March 31, 2024 | $429.26M | +5.6% | +14.3% |
| September 30, 2023 | $375.71M | -2.2% | -6.2% |
| June 30, 2023 | $400.75M | +15.4% | -1.4% |
- INCYTE CORP showed a decrease of -21.4% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, INCYTE CORP’s r&d expense has grown by 1616.4% (from $119.44 million to $2.05 billion).
- The most recent figure is from INCYTE CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: